Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 9th May 2024 CYCC stock ended at $2.31. This is 0.431% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 14.48% from a day low at $2.27 to a day high of $2.60.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Jul 06, 2016 $5.02 $5.23 $4.90 $5.00 22 700
Jul 05, 2016 $5.03 $5.30 $5.03 $5.13 8 700
Jul 01, 2016 $5.07 $5.33 $4.98 $5.02 10 400
Jun 30, 2016 $5.29 $5.35 $5.02 $5.02 6 500
Jun 29, 2016 $5.54 $5.54 $4.88 $5.20 24 200
Jun 28, 2016 $4.59 $5.09 $4.59 $4.81 25 100
Jun 27, 2016 $5.17 $5.18 $4.55 $4.59 59 400
Jun 24, 2016 $4.97 $5.36 $4.97 $5.14 70 600
Jun 23, 2016 $5.32 $5.55 $5.15 $5.27 39 800
Jun 22, 2016 $5.27 $5.72 $5.22 $5.22 13 200
Jun 21, 2016 $5.17 $5.56 $5.17 $5.39 41 500
Jun 20, 2016 $5.49 $5.72 $5.12 $5.12 105 900
Jun 17, 2016 $5.27 $5.61 $5.15 $5.48 31 000
Jun 16, 2016 $5.72 $5.72 $5.13 $5.33 160 298
Jun 15, 2016 $5.76 $5.89 $5.68 $5.76 16 850
Jun 14, 2016 $5.50 $5.86 $5.40 $5.76 19 610
Jun 13, 2016 $5.95 $5.95 $5.33 $5.47 44 200
Jun 10, 2016 $6.10 $6.19 $5.75 $5.95 34 472
Jun 09, 2016 $5.99 $6.42 $5.86 $6.09 94 012
Jun 08, 2016 $5.83 $6.14 $5.69 $6.00 128 810
Jun 07, 2016 $5.90 $6.20 $5.61 $5.75 238 962
Jun 06, 2016 $4.26 $8.27 $4.26 $6.43 3 925 518
Jun 03, 2016 $4.54 $4.63 $4.21 $4.40 36 927
Jun 02, 2016 $4.40 $4.58 $4.26 $4.58 17 666
Jun 01, 2016 $4.09 $5.08 $4.09 $4.31 151 574
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT